The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kommera Harish
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mr. Kommera Harish, identified as a non-promoter, was allotted 26,98,140 equity shares of Astal Laboratories Ltd on 14 January 2026 through a preferential allotment pursuant to a share swap. His holding increased from 1,17,000 shares (1.09% of share capital) to 28,15,140 shares (6.67% of share capital). The allotment caused the company's equity share capital to expand nearly four-fold, from Rs. 10.77 crore (1.07 crore shares) to Rs. 42.22 crore (4.22 crore shares), suggesting the share swap was part of a larger acquisition deal where Astal Laboratories likely issued shares to acquire another entity/business.
Significant dilution for existing shareholders due to a ~4x expansion of the equity base, though no cash outflow is involved as this is a share-swap arrangement. The non-promoter stakeholder now holds over 6.6%, but is not classified as a promoter and no takeover/open offer trigger is being declared.